Vera Kovacevic

3 weeks ago | xtalks.com | Vera Kovacevic

As we prepare to release Issue 5, the next edition of Xtalks Clinical Edge™, our focus remains on the future of clinical trials — offering expert insights, exclusive interviews and strategies to drive innovation in clinical research. With a highly engaged audience of over 86,000 clinical trial professionals, the magazine is a trusted platform for thought leadership at the intersection of science, technology and patient care.

4 weeks ago | xtalks.com | Vera Kovacevic

As the global life sciences industry continues to evolve, regions around the world are vying for leadership in biotech, pharma, medical devices and digital health. North America has long been a hub for innovation, with strong investment ecosystems and top-tier research institutions. Meanwhile, Europe’s regulatory rigor and public-private partnerships have made it a formidable player, and Asia-Pacific is rapidly advancing with significant government backing and a growing clinical trial footprint.

1 month ago | xtalks.com | Vera Kovacevic

Diabetes affects hundreds of millions worldwide — currently, about 537 million people live with the condition, with projections reaching nearly 643 million by 2030. These figures underline the urgency for novel and more effective treatment strategies, particularly for type 1 diabetes (T1D). Although T1D accounts for only about 5% to 10% of all diabetes cases, its onset at a young age and the need for lifelong management present unique challenges.

1 month ago | xtalks.com | Vera Kovacevic

Digital health is reshaping clinical research and care delivery by offering more comprehensive insights into patient health. In traditional clinical trials, endpoints — measurable outcomes such as lab results, imaging studies or clinical assessments — are collected during scheduled visits at the clinic. In contrast, digital endpoints are derived from data captured continuously or intermittently through digital health technologies (DHTs), often outside of a clinical setting.

1 month ago | xtalks.com | Vera Kovacevic

Cancer remains one of the most significant health challenges, with millions of new cases each year. In the US alone, roughly 1.8 million new cancer cases are diagnosed annually​, and the vast majority (~90%) of these are solid tumors (cancers of organs such as the breast, lung or colon)​. Globally, cancer incidence is on the rise.